Qingdao NovelBeam Technology Co Ltd
SSE:688677
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.73
59.09
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Qingdao NovelBeam Technology Co Ltd stock under the Base Case scenario is 56.34 CNY. Compared to the current market price of 35.83 CNY, Qingdao NovelBeam Technology Co Ltd is Undervalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Qingdao NovelBeam Technology Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Qingdao NovelBeam Technology Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 854 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Qingdao NovelBeam Technology Co Ltd
Balance Sheet Decomposition
Qingdao NovelBeam Technology Co Ltd
Current Assets | 830.8m |
Cash & Short-Term Investments | 545.5m |
Receivables | 97.9m |
Other Current Assets | 187.4m |
Non-Current Assets | 565.1m |
Long-Term Investments | 78.7m |
PP&E | 430.9m |
Intangibles | 29.6m |
Other Non-Current Assets | 25.9m |
Current Liabilities | 71.3m |
Accounts Payable | 40.5m |
Accrued Liabilities | 12.9m |
Other Current Liabilities | 17.9m |
Non-Current Liabilities | 42.9m |
Long-Term Debt | 31.8m |
Other Non-Current Liabilities | 11.1m |
Earnings Waterfall
Qingdao NovelBeam Technology Co Ltd
Revenue
|
413m
CNY
|
Cost of Revenue
|
-149.3m
CNY
|
Gross Profit
|
263.7m
CNY
|
Operating Expenses
|
-127.8m
CNY
|
Operating Income
|
135.9m
CNY
|
Other Expenses
|
-11m
CNY
|
Net Income
|
124.9m
CNY
|
Free Cash Flow Analysis
Qingdao NovelBeam Technology Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Qingdao NovelBeam Technology Co Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Qingdao NovelBeam Technology Co Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Qingdao NovelBeam Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Qingdao NovelBeam Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Qingdao NovelBeam Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for Qingdao NovelBeam Technology Co Ltd is 63.75 CNY with a low forecast of 63.13 CNY and a high forecast of 65.63 CNY.
Dividends
Current shareholder yield for Qingdao NovelBeam Technology Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Qingdao NovelBeam Technology Co Ltd stock under the Base Case scenario is 56.34 CNY.
Compared to the current market price of 35.83 CNY, Qingdao NovelBeam Technology Co Ltd is Undervalued by 36%.